# Tim Juergens

> Tim Juergens is a pre-seed investor in Barcelona backing Health Care and Personal Health. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Location: Barcelona, Spain
- Total investments: 5
- Last investment: May 2024
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/tim-juergens-gm/

Tim Juergens is a Co-Founder & General Manager of SeedLink SL.

## Round sizes

| Stage | Round size |
| --- | --- |
| Pre-Seed | $269k–$1.2M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 80% |
| Personal Health | 2 | 40% |
| Medical | 1 | 20% |
| mHealth | 1 | 20% |
| Diabetes | 1 | 20% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 3 | 60% |
| Seed | 2 | 40% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 3 | 60% |
| Switzerland | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OneTwenty | OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes. |  | Seed | Mar 01, 2025 |  |
| Hale | Precision care for genito-pelvic pain. | $269.3K | Pre-Seed | May 12, 2024 |  |
| OneTwenty | OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes. |  | Pre-Seed | Jan 19, 2024 |  |
| Skinuvita | Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home. | $1.2M | Pre-Seed | Apr 01, 2022 |  |
| XO Life | XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications. | $2.3M | Seed | Feb 16, 2022 |  |

5 of 5 investments shown.

## Co-investors
- [DvH Ventures](https://shizune.co/investors/profile/dvh-ventures) — VC Fund, 3 deals together
- [Tiny Supercomputer Investment Company](https://shizune.co/investors/profile/tiny-vc) — VC Fund, 2 deals together
- [1921](https://shizune.co/investors/profile/1921) — VC Fund, 1 deal together
- [Aescuvest](https://shizune.co/investors/profile/aescuvest) — VC Fund, 1 deal together
- [GCP-Service Invest](https://shizune.co/investors/profile/gcp-service-invest) — VC Fund, 1 deal together
- [Growing Well Partners](https://shizune.co/investors/profile/growing-well-partners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [Health Care Angel Investors in Switzerland](https://shizune.co/investors/health-care-angel-investors-switzerland)
- [Artificial intelligence Angel Investors in Switzerland](https://shizune.co/investors/artificial-intelligence-angel-investors-switzerland)
- [Mobile Angel Investors in Switzerland](https://shizune.co/investors/mobile-angel-investors-switzerland)
- [Machine Learning Angel Investors in Switzerland](https://shizune.co/investors/machine-learning-angel-investors-switzerland)
- [Machine Learning Investors in Switzerland](https://shizune.co/investors/machine-learning-investors-switzerland)

## FAQ

### What does Tim Juergens invest in?

Tim Juergens invests primarily in Health Care, Personal Health and Medical startups, most often at Pre-Seed and Seed stage. Most of the 5 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Tim Juergens's check size?

Tim Juergens typically joins rounds of $269k–$1.2M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tim Juergens participates in.

### When did Tim Juergens last invest?

The most recent investment recorded for Tim Juergens closed in May 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co